Related Experiment Video
Updated: Aug 21, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
[Clinical management of patients with depression and cardiac disease]
Marcelo Camprubli1, Marcos Suffriti
1Guy's Hospital, Londres, Reino Unido. mecamprubi@yahoo.co.uk
Insights
Depression affects up to 20% of patients with acute coronary syndromes, increasing risks. Selective serotonin reuptake inhibitors are effective and safe treatments that may improve survival in these patients.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Depression is prevalent in acute coronary syndrome (ACS) patients, affecting 15-20%.
- Depression independently elevates morbidity and mortality risks in ACS patients.
- Effective treatment for depression in cardiac patients is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) for treating depression in patients with acute coronary syndromes.
- To determine if SSRI treatment impacts survival rates post-myocardial infarction in depressed cardiac patients.
Main Methods:
- The study focuses on patients with acute coronary syndromes and depression.
- Treatment involved selective serotonin reuptake inhibitors.
- Outcomes assessed included treatment effectiveness, safety, and survival after myocardial infarction.
Main Results:
- Selective serotonin reuptake inhibitors demonstrated effectiveness and safety in treating depression.
- SSRI treatment was associated with potential improvements in survival after myocardial infarction.
Conclusions:
- Selective serotonin reuptake inhibitors represent an effective and safe therapeutic option for depression in patients with acute coronary syndromes.
- SSRI treatment may offer survival benefits for patients experiencing myocardial infarction and depression.
Abstract:
Depression occurs in 15 % to 20 % of patients with acute coronary syndromes and it is also and independent risk factor for morbidity and mortality. Treatment with selective serotonin reuptake inhibitors is effective, safe and may improve survival after myocardial infarction in patients with depression.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Cardiomyopathy VI: Nursing Management
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
